Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue‐specific fibrin deposition
Open Access
- 19 December 2007
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 6 (1) , 111-117
- https://doi.org/10.1111/j.1538-7836.2007.02817.x
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Vascular bed-specific thrombosisJournal of Thrombosis and Haemostasis, 2007
- Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothersThe Journal of Experimental Medicine, 2007
- Active tissue factor pathway inhibitor is expressed on the surface of coated plateletsBlood, 2006
- The quest for the Holy Grail of tissue factor pathway inhibitor deficiency has just begunJournal of Thrombosis and Haemostasis, 2005
- A murine model of deep vein thrombosis Characterization and validation in transgenic miceThrombosis and Haemostasis, 2005
- Total tissue factor pathway inhibitor is an independent risk factor for symptomatic paediatric venous thromboembolism and strokeThrombosis and Haemostasis, 2004
- Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosisBlood, 2003
- Thrombomodulin Expression in Bovine Brain CapillariesArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Blocking of tissue factor pathway inhibitor (TFPl) shortens the bleeding time in rabbits with antibody induced haemophilia ABlood Coagulation & Fibrinolysis, 1995
- Simultaneous Demonstration of Connective Tissue elastica and Fibrin by a Combined Verhoeff's Elastic-Martius-Scarlet-Blue Trichrome StainStain Technology, 1984